Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysis (Q33383403)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

0 references

Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

Daniele Santini

object named as

Daniele Santini

5

0 references

6

object named as

Bruno Vincenzi

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1

object named as

Antonio Russo

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

4

object named as

Vincenzo Adamo

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

3

object named as

Fabio Fulfaro

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Sergio Rizzo

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Nicola Gebbia

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ignazio Carreca

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

1 May 2009

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

115

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1924-1931

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Re: Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24207

21 January 2018

Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24207

21 January 2018

Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24207

7 January 2021

based on heuristic

inferred from DOI database lookup

Underrepresentation of patients 65 years of age or older in cancer-treatment trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24207

7 January 2021

based on heuristic

inferred from DOI database lookup

Participation of patients 65 years of age or older in cancer clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24207

7 January 2021

based on heuristic

inferred from DOI database lookup

Physicians' judgement and comprehensive geriatric assessment (CGA) select different patients as fit for chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24207

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24207

7 January 2021

based on heuristic

inferred from DOI database lookup

Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24207

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, Stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24207

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: the MILES-2P studies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24207

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24207

7 January 2021

based on heuristic

inferred from DOI database lookup

American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24207

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24207

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24207

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine monotherapy in elderly patients with advanced non-small cell lung cancer: a multicenter phase II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24207

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24207

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24207

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine plus vinorelbine yields better survival outcome than vinorelbine alone in elderly patients with advanced non-small cell lung cancer. A Southern Italy Cooperative Oncology Group (SICOG) phase III trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24207

7 January 2021

based on heuristic

inferred from DOI database lookup

Weekly docetaxel versus docetaxel/gemcitabine in the treatment of elderly or poor performance status patients with advanced nonsmall cell lung cancer: a randomized phase 3 trial of the Minnie Pearl Cancer Research Network

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24207

7 January 2021

based on heuristic

inferred from DOI database lookup

Lung cancer in the elderly

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24207

7 January 2021

based on heuristic

inferred from DOI database lookup

Carboplatin-oral etoposide personalized dosing in elderly non-small cell lung cancer patients. Gruppo Oncologico Cooperativo Sud-Italia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24207

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24207

7 January 2021

based on heuristic

inferred from DOI database lookup

Elderly Patients Benefit From Second-Line Cytotoxic Chemotherapy: A Subset Analysis of a Randomized Phase III Trial of Pemetrexed Compared With Docetaxel in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24207

7 January 2021

based on heuristic

inferred from DOI database lookup

Erlotinib for advanced non-small-cell lung cancer in the elderly: an analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24207

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.24207

1 reference

https://api.fatcat.wiki/v0/release/w2egddjyqvbfhfnsforrlfcrmi

30 July 2022

based on heuristic

mapped directly with Wikidata item

release_w2egddjyqvbfhfnsforrlfcrmi

1 reference

https://api.fatcat.wiki/v0/release/w2egddjyqvbfhfnsforrlfcrmi

30 July 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

https://api.fatcat.wiki/v0/release/w2egddjyqvbfhfnsforrlfcrmi

30 July 2022

based on heuristic

mapped directly with Wikidata item

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33383403&oldid=1988477315"